Skip to Content

Join the 'Short Bowel Syndrome' group to help and get support from people like you.

Short Bowel Syndrome News

FDA Approves Gattex to Treat Short Bowel Syndrome

Posted 21 Dec 2012 by Drugs.com

December 21, 2012 – The U.S. Food and Drug Administration today approved Gattex (teduglutide) to treat adults with short bowel syndrome (SBS) who need additional nutrition from intravenous feeding (parenteral nutrition). SBS is a condition that results from the partial or complete surgical removal of the small and/or large intestine. Extensive loss of the small intestine can lead to poor absorption of fluids and nutrients from food needed to sustain life. As a result, patients with SBS often receive parenteral nutrition. Gattex is an injection administered once daily that helps improve intestinal absorption of fluids and nutrients, reducing the frequency and volume of parenteral nutrition. It is the third FDA-approved drug to treat adults with SBS receiving nutritional support. Zorbtive (somatropin) and Nutrestore (glutamine) were approved in 2003 and 2004, respectively. “Today’s app ... Read more

Related support groups: Short Bowel Syndrome

Ask a Question

Further Information

Related Condition Support Groups

Malabsorption Syndrome

Related Drug Support Groups

somatropin, glutamine, Gattex, SYMPT-X G.I., Norditropin FlexPro, NutreStore, HumatroPen, Norditropin Nordiflex, teduglutide, Zorbtive, Accretropin, GlutaSolve